Sign In
Buy DGX
$233.01
-1.29 (-0.551%)
At Close: Jul 31, 2026
Should You Continue to Hold DGX Stock in Your Portfolio?
09:25am, Tuesday, 10'th Mar 2026
Quest Diagnostics posts strong gains from physician and hospital channels while advancing AI-powered solutions.
Cresset Asset Management LLC Has $1.36 Million Holdings in Quest Diagnostics Incorporated $DGX
04:37am, Tuesday, 10'th Mar 2026
Cresset Asset Management LLC raised its position in shares of Quest Diagnostics Incorporated (NYSE: DGX) by 78.1% in the third quarter, according to the company in its most recent disclosure with the
Quest Diagnostics Incorporated $DGX Shares Purchased by Blair William & Co. IL
03:38am, Monday, 09'th Mar 2026
Blair William and Co. IL raised its holdings in shares of Quest Diagnostics Incorporated (NYSE: DGX) by 7.4% in the undefined quarter, according to the company in its most recent 13F filing with the S
Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results
09:02am, Monday, 02'nd Mar 2026
New feature based on Google's Gemini seamlessly analyzes up to five years of personal lab data to help explain results and uncover potential health risks SECAUCUS, N.J., March 2, 2026 /PRNewswire/ --
Digi Power X Graduates to Cboe Canada
10:00am, Friday, 27'th Feb 2026
TORONTO--(BUSINESS WIRE)---- $DGX #Cboe--Digi Power X Inc. has graduated from the venture markets and is now listed under the symbol DGX on Cboe Canada,.
Quest Diagnostics Incorporated (NYSE:DGX) Receives Average Recommendation of “Moderate Buy” from Brokerages
01:58am, Friday, 27'th Feb 2026
Shares of Quest Diagnostics Incorporated (NYSE: DGX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the sixteen ratings firms that are presently covering the stock, MarketBe
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
10:51am, Thursday, 26'th Feb 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer
08:24am, Thursday, 26'th Feb 2026
Veteran M&A and transformation leader from Danaher and Patheon joins the Quest Diagnostics executive team SECAUCUS, N.J., Feb. 26, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provi
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference
10:00am, Wednesday, 25'th Feb 2026
SECAUCUS, N.J., Feb. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President & Chief Finan
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
10:41am, Tuesday, 24'th Feb 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Insider Selling: Quest Diagnostics (NYSE:DGX) SVP Sells $196,227.14 in Stock
05:52am, Monday, 23'rd Feb 2026
Quest Diagnostics Incorporated (NYSE: DGX - Get Free Report) SVP Patrick Plewman sold 958 shares of the business's stock in a transaction dated Thursday, February 19th. The shares were sold at an aver
Compass Wealth Management LLC Makes New Investment in Quest Diagnostics Incorporated $DGX
04:08am, Saturday, 21'st Feb 2026
Compass Wealth Management LLC bought a new position in Quest Diagnostics Incorporated (NYSE: DGX) in the undefined quarter, according to the company in its most recent filing with the Securities and E
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?
10:16am, Wednesday, 11'th Feb 2026
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Quest Diagnostics CEO on using blood testing for Alzheimer's diagnosis
04:34pm, Tuesday, 10'th Feb 2026
Quest Diagnostics CEO Jim Davis says the company's Alzheimer's testing through blood work can help disagnons the disease a lot sooner and get patients into specialist earlier.
Consolidated Revenues: $2.81 billion, up 7.1% year-over-year.Organic Revenue Growth: 6.4% in the fourth quarter.Diagnostic Information Services Revenue Growth:
